Spectrum Pharmaceutecals Inc (SPPI)

[antihama]

If expected poziotinib/Rolontis data is bullish than I'd say that the share price would get to $30 without any takeover rumors. I'm a bird in the hand kind of guy (takeover bid of $30) but in this case I'd rather go for 2 birds in the bush (bullish data/news for poziotinib and Rolontis then entertain licensing agreements/takeovers). If you think pozi has a $500M potential and using the Price to Sales Ratio determined by NYU Stern School of Business which was updated in Jan 2017 of 5.86 for all Biotechs pozi is worth $30/share. If you think pozi has $1B sales potential than pozi is worth $60/share. So even though more often than not I’m a bird in the hand type, I’d rather wait till we hear more news next quarter. I don’t think that is much of a gamble.